Terlypressin and endoscopic sclerotherapy control variceal bleeding and prevent early rebleeding in cirrhotic patients
- 30 November 1993
- journal article
- Published by Elsevier in Current Therapeutic Research
- Vol. 54 (5) , 519-528
- https://doi.org/10.1016/s0011-393x(05)80671-x
Abstract
No abstract availableKeywords
This publication has 23 references indexed in Scilit:
- Haemodynamic effect of triglycyl-lysine-vasopressin (glypressin) on intravascular oesophageal variceal pressure in patients with cirrhosisJournal of Hepatology, 1990
- Controlled clinical trial of injection sclerotherapy for active variceal bleedingHepatology, 1989
- Prediction of the First Variceal Hemorrhage in Patients with Cirrhosis of the Liver and Esophageal VaricesNew England Journal of Medicine, 1988
- Einfluß von Glycylpressin auf den Ösophagusvarizendruck bei Patienten mit Leberzirrhose und vorangegangener VarizenblutungDeutsche Medizinische Wochenschrift (1946), 1987
- Acute Esophageal Variceal SclerotherapyJAMA, 1986
- Improved Survival Following Injection Sclerotherapy for Esophageal Varices: Final Analysis of A Controlled TrialHepatology, 1985
- Endoscopic Sclerosis and Esophageal Balloon Tamponade in Acute Hemorrhage From Esophagogastric Varices: A Prospective Controlled Randomized TrialHepatology, 1985
- A Prospective, Randomized Controlled Trial of Chronic Esophageal Variceal SclerotherapyHepatology, 1985
- Sclerotherapy after First Variceal Hemorrhage in CirrhosisNew England Journal of Medicine, 1984
- FAILURE OF REPEATED INJECTION SCLEROTHERAPY TO IMPROVE LONG-TERM SURVIVAL AFTER OESOPHAGEAL VARICEAL BLEEDINGThe Lancet, 1983